Patents Examined by Iqbal Chowdhury
-
Patent number: 7435434Abstract: The invention relates to an S thermophilus bacterium which is resistant to attack by at least one bacteriophage, a method of production of the bacterium and a composition which comprises the bacterium. The bacterium comprises a modification of the Sfi21 prophage or the bacterial genome which disrupts expression of a gene which is essential to a bacteriophage, but not essential to the bacteria.Type: GrantFiled: August 8, 2000Date of Patent: October 14, 2008Assignee: Nestec S.A.Inventors: Harald Bruessow, Sacha Lucchini
-
Patent number: 7425434Abstract: The invention relates to a new strain of Pseudomonas putida (designated as HI-70) and to the isolation, cloning, and sequencing of a cyclododecanone monooxygenase-encoding gene (named cdnB) from said strain. The invention also relates to a new cyclododecanone monooxygenase and to a method of use of the cyclododecanone monooxygenase-encoding gene.Type: GrantFiled: March 13, 2007Date of Patent: September 16, 2008Assignee: National Research Council of CanadaInventors: Hiroaki Iwaki, Yoshie Hasegawa, Peter C. K. Lau
-
Patent number: 7419815Abstract: The invention relates to a method of identifying herbicides and to the use of inhibitors of plant peptide deformylase as broad spectrum herbicides.Type: GrantFiled: October 8, 2003Date of Patent: September 2, 2008Assignee: University of Kentucky Research FoundationInventors: Robert L. Houtz, Lynnette M. A. Dirk, Mark Alan Williams
-
Patent number: 7416723Abstract: In one embodiment, a therapeutic composition containing a pentavalent antimonial is provided. The pentavalent antimonial can be sodium stibogluconate, levamisole, ketoconazole, and pentamidine and biological equivalents of said compounds. Additionally, pentavalent antimonials that can be used in accordance with the present invention may be any such compounds which are anti-leishmaniasis agents. The therapeutic composition of this embodiment contains an effective amount of pentavalent antimonial that can be used in treating infectious diseases. The types of diseases that can be treated with the present invention include, but are not limited to, the following: diseases associated with PTPase activity, immune deficiency, cancer, infections (such as viral infections), hepatitis B, and hepatitis C. The types of cancers that the present embodiment can be used to treat include those such as lymphoma, multiple myeloma, leukemia, melanoma, prostate cancer, breast cancer, renal cancer, bladder cancer.Type: GrantFiled: September 9, 2002Date of Patent: August 26, 2008Assignee: The Cleveland Clinic FoundationInventor: Taolin Yi
-
Patent number: 7413735Abstract: The present invention relates to a pharmaceutical composition for inhibiting angiogenesis which comprises arginine deiminase as an active ingredient, where the arginine deiminase, obtained from Mycoplasma arginini or prepared by a genetic recombination technique, may be conjugated to an activated polymer to lower its immunogenecity and increase its life time. The pharmaceutical composition of the present invention exhibits an excellent inhibitory activity against angiogenesis.Type: GrantFiled: June 20, 2005Date of Patent: August 19, 2008Assignee: Angio Lab, Inc.Inventors: Bon-Hong Min, Myung-Ok Park, Min-Young Kim, Byung-Young Park, Boe-Gwun Chun, Sang-Wook Kang, Chang-Hee Moon
-
Patent number: 7410786Abstract: A gene encoding a polypeptide having an activity of digesting sulfated fucogalactan which is useful in sugar chain engineering reagents, analyzing the structures of sulfated fucose-containing polysaccharides and preparing degraded products of the polysaccharides; a genetic engineering process for producing the polypeptide; and the polypeptide obtained by the process.Type: GrantFiled: March 2, 2007Date of Patent: August 12, 2008Assignee: Takara Bio. Inc.Inventors: Harumi Ueno, Jun Tomono, Hiroaki Sagawa, Takeshi Sakai, Ikunoshin Kato
-
Patent number: 7393673Abstract: The invention provides a thermal tolerant cellulase that is a member of the glycoside hydrolase family. The invention further discloses this cellulase as Gux1. Gux1 has been isolated and characterized from Acidothermus cellulolyticus. The invention further provides recombinant forms of the identified Gux1. Methods of making and using Gux1 polypeptides, including fusions, variants, and derivatives, are also disclosed.Type: GrantFiled: July 28, 2001Date of Patent: July 1, 2008Assignee: Midwest Research InstituteInventors: William S. Adney, Shi-You Ding, Todd B. Vinzant, Michael E. Himmel, Stephen R. Decker, Suzanne Lantz McCarter
-
Patent number: 7374921Abstract: Disclosed is a novel cellulase having an amino acid sequence in which the 162nd and/or 166th amino acid residues in the amino acid sequence of cellulase NCE5 are substituted. Further, a polynucleotide encoding the novel cellulase, an expression vector containing the polynucleotide, a host cell transformed with the expression vector, and a cellulase preparation and a washing composition containing the cellulase are disclosed. The cellulase of the present invention is resistant to surfactants, and maintains a high activity even under alkaline conditions.Type: GrantFiled: October 31, 2003Date of Patent: May 20, 2008Assignee: Meiji Seika Kaisha, Ltd.Inventors: Kaoru Okakura, Koji Yanai
-
Patent number: 7371555Abstract: The invention relates to isolated polypeptides having ?-H-?-amino acid amide racemase activity and nucleic acids encoding the same. The invention also relates to vectors and host cells comprising the nucleic acids according to the invention. The invention also relates to methods of producing and using the polypeptides according to the invention. The invention also relates to a method for isolating polypeptides having ?-H-?-amino acid amide racemase activity, for isolating nucleic acids encoding the same and for isolating microorganisms comprising polypeptides having ?-H-?-amino acid amide racemase activity. The invention also relates to new microorganisms comprising polypeptides having ?-H-?-amino acid amide racemase activity.Type: GrantFiled: December 9, 2003Date of Patent: May 13, 2008Assignee: DSM IP Assets B.V.Inventors: Wilhelmus Hubertus Joseph Boesten, Petronella Catharina Raemakers-Franken, Theodorus Sonke, Gerrit Jan Willem Euverink, Pieter Grijpstra
-
Patent number: 7371554Abstract: It is an object of the present invention to provide isozymes of the lachrymatory factor producing enzyme, the amino acid sequences of these isozymes and a gene that codes for these amino acid sequences, and the present invention relates to three types of isozymes of the lachrymatory factor producing enzyme that contributes to the production of the lachrymatory factor that is present in onions and the like, amino acid sequences indicated by SEQ ID Nos. 1 to 3 which constitute the proteins or polypeptides of these isozymes, DNA indicated by SEQ ID Nos.Type: GrantFiled: August 30, 2001Date of Patent: May 13, 2008Assignee: House Foods CorporationInventors: Shinsuke Imai, Nobuaki Tsuge, Muneaki Tomotake
-
Patent number: 7371558Abstract: The present invention provides a microorganism useful for biologically producing 1,3-propanediol from a fermentable carbon source at higher yield than was previously known. The complexity of the cofactor requirements necessitates the use of a whole cell catalyst for an industrial process that utilizes this reaction sequence to produce 1,3-propanediol. The invention provides a microorganism with disruptions in specified genes and alterations in the expression levels of specified genes that is useful in a higher yielding process to produce 1,3-propanediol.Type: GrantFiled: October 6, 2003Date of Patent: May 13, 2008Assignees: E.I. du Pont de Nemours and Company, Genencor InternationalInventors: Marguerite A. Cervin, Phillipe Soucaille, Fernando Valle
-
Patent number: 7368237Abstract: An assay uses apoptotic nucleases to screen for apoptosis modulators, in a method of modulating apoptosis, and in a method of aiding in a diagnosis of a disease, among other methods. materials for use in the assay include isolated or recombinant polypeptides and polynucleotides, compositions comprising those isolated or recombinant polypeptides and polynucleotides, vectors, transgenic organisms, and integrated systems among other aspects.Type: GrantFiled: April 23, 2004Date of Patent: May 6, 2008Inventors: Jay Parrish, Ding Xue
-
Patent number: 7364889Abstract: A catalytically active peptide comprising an imidazole function in position i flanked by at least one functional group to be amidated in position i+3+4k, where k is an integer equal to or higher than ?1 or in position i?4?4n, wherein n is an integer equal to or higher than 0, characterized in that it also comprises at least one activating group in position i+4+4n or i?3?4n, respectively, wherein n is as above.Type: GrantFiled: April 4, 2006Date of Patent: April 29, 2008Assignee: Modpro ABInventor: Lars Baltzer
-
Patent number: 7364883Abstract: The present invention is directed to a process of producing novel fatty acids in oleaginous yeast by producing oleaginous yeast by introducing into the yeast genes coding for enzymes selected from the group consisting of D5-desaturase, D6-desaturase, D12-desaturase, D15-desaturase and elongase; and culturing the yeast in the medium containing high levels of carbon sources. The present invention is further directed to a residue or fatty acid that is obtained from pressing the oleaginous yeast produced by the process of the invention.Type: GrantFiled: May 6, 2005Date of Patent: April 29, 2008Assignee: Yeastern BioTech Co., Ltd.Inventor: Tzu-Chih Chen
-
Patent number: 7354741Abstract: A vector of the present invention has DNA encoding a protein or a product having the same effect as the protein, the protein containing an amino acid sequence from amino acid numbers 47 to 802 in SEQ. ID. NO:2. Expression of the DNA gives human chondroitin synthase. By using human chondroitin synthase, it is possible to produce a saccharide chain having a repeating disaccharide unit of chondroitin. The DNA or part thereof may be used as a probe for hybridization for the human chondroitin synthase.Type: GrantFiled: November 15, 2006Date of Patent: April 8, 2008Assignee: Otsuka Chemical Co., Ltd.Inventors: Kazuyuki Sugahara, Hiroshi Kitagawa
-
Patent number: 7351542Abstract: The present invention provides methods for identifying agents that modulate a level or an activity of tubulin deacetylase polypeptide, as well as agents identified by the methods. The invention further provides methods of modulating tubulin deacetylase activity in a cell. The invention further provides methods of modulating cellular proliferation by modulating the activity of tubulin deacetylase.Type: GrantFiled: May 19, 2003Date of Patent: April 1, 2008Assignee: The Regents of the University of CaliforniaInventors: Eric M. Verdin, Brian J. North, Scott M. Ulrich
-
Patent number: 7348168Abstract: The present invention relates to polypeptides having cellobiohydrolase II activity and polynucleotides having a nucleotide sequence, which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.Type: GrantFiled: December 19, 2003Date of Patent: March 25, 2008Assignee: Novozymes A/SInventors: Wenping Wu, Lene Lange, Dominique Aubert Skovlund, Ye Liu
-
Patent number: 7348172Abstract: The invention is related to a method and DNA constructs for obtaining in a filamentous fungus host a higher production level of a carbohydrate degrading (CD) enzyme, having in its original state a catalytic module (CAT) and a carbohydrate binding module (CBM) separated by a linker region. The DNA construct comprising a truncated actinomycetes, preferably Nonomuraea flexuosa (NJ) derived DNA sequence encoding a truncated form of the CD enzyme, for example Nf Xyn11A, Nf Xyn10A, and is introduced into a filamentous fungal host. Said CD enzyme contains the catalytically active region of CAT but lacks part or all of the CBM, or all of the CBM and part or all of the linker region and is expressed and secreted under the control of regulatory sequences comprising at least a signal sequence, but also promoters, terminators and DNA sequences encoding a secretable carrier protein or domains thereof, preferably originating from filamentous fungi are included.Type: GrantFiled: April 18, 2005Date of Patent: March 25, 2008Assignee: AB Enzymes OyInventors: Marja Paloheimo, Arja Mantyla, Sanna Leskinen, Richard Fagerstrom, Jarno Kallio, Terhi Puranen, Raija Lantto, Pirkko Suominen
-
Patent number: 7341859Abstract: The present invention relates to an alcohol dehydrogenase from Rhodococcus erythropolis. By means of such cofactor-dependent ADHs, chiral alcohols, which can be of use for use in organic syntheses, can advantageously be obtained with a cofactor-regenerating enzyme in a coupled enzymatic system. A nucleotide sequence, vehicles containing this, a polypeptide sequence and processes for mutation and use of the sequences are claimed.Type: GrantFiled: April 1, 2003Date of Patent: March 11, 2008Assignee: Degussa AGInventors: Werner Hummel, Kofi Abokitse, Harald Groeger
-
Patent number: 7338776Abstract: A purified novel enzyme protein, UGPPase, which naturally occurs in animal cells, its productions of recombinant technology, an antibody to the enzyme protein, a method of carrying out ELISA for measurement of the amount of UGPPase in an analyte and a method for determination of UDPG in a sample. The one-way enzyme protein catalyses hydrolysis of UDP-glucose, the precursor molecule of glycogen, into glucose-1-phosphate (G1P) and uridine 5?-monophosphate (UMP).Type: GrantFiled: March 17, 2003Date of Patent: March 4, 2008Assignees: JCR Pharmaceuticals Co., Ltd., Universidad Publica De Navarra Campus ArrosadiaInventors: Javier Pozueta Romero, Edurne Baroja Fernandez, Francisco Jose Munoz, Imbak Shu, Ryuji Yamamoto